AMAkihiro Matsumi

Akihiro Matsumi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Akihiro Matsumi has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Segment‐Specific Occlusion of Retrieved Plastic Biliary Stents: Direct Quantification and Microbial and Material Determinants

    by Akihiro Matsumi, Kazuyuki Matsumoto, Kentaro Oki, Satoshi Kajitani, Ryosuke Sato, Tatsuya Kikuchi, Kazuya Miyamoto, Hiroyuki Terasawa, Yuki Fujii, Daisuke Uchida, et al.

    Objectives: Plastic stents (PS) are widely used for biliary drainage, with occlusion mainly caused by biofilm formation and sludge accumulation. However, direct evaluation of luminal occlusion remains limited, and its spatial distribution is poorly understood. This study aimed to quantify luminal occlusion in retrieved PS and identify associated factors. Methods: In this prospective observational study, 64 patients (196 stents) undergoing scheduled PS exchange at approximately 3‐month intervals were included. Retrieved stents were divided into proximal, central, and distal segments, and occlusion was quantified using ImageJ. Clinical, microbiological, and device‐related variables were analyzed. Multivariable linear regression was used to identify independent factors associated with occlusion. Results: The mean occlusion rate was 28.8% ± 29.8%. Occlusion was significantly higher in the proximal segment than in the central and distal segments (35.5% vs. 25.8% and 25.0%; p < 0.05). Multivariable analysis showed that age > 65 years (β = 11.62, p = 0.006), Enterococcus‐positive bile culture (β = 16.00, p = 0.012), and probiotic use (β = 14.91, p = 0.007) were independently associated with increased occlusion. Stent brand was also associated with the degree of occlusion. Conclusions: Plastic stent occlusion is segment‐dependent, predominantly affecting the proximal portion, and is associated with microbiological and material‐related factors. Direct quantification may help optimize stent design and management.

  • Open Access

    Long-Term Outcomes of Endoscopic Ultrasound-Guided Gallbladder Drainage for Acute Cholecystitis in Non-Surgical Candidates: A Multicenter Retrospective Study

    by Kei Harada, Kazuya Miyamoto, Kazuyuki Matsumoto, Kosaku Morimoto, Eijiro Ueta, Yutaka Akimoto, Nao Hattori, Taisuke Obata, Ryosuke Sato, Akihiro Matsumi, et al.

    Background/Objectives: Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) is a minimally invasive alternative for managing acute cholecystitis in patients who are unsuitable for surgery. Although its short-term efficacy is well-established, its long-term outcomes, especially in patients with malignancy-associated cholecystitis, remain unclear. Methods: This multicenter, retrospective study included 139 patients who underwent EUS-GBD with a plastic stent for inoperable acute cholecystitis between January 2010 and October 2023. Patients were divided into two groups: a malignant group (n = 60) with cystic duct obstruction caused by cancer invasion or self-expandable metal stents, and a benign group (n = 79) with calculous or acalculous cholecystitis. The outcomes assessed included cholecystitis recurrence, time to recurrence, adverse events, and risk factors for recurrence. Results: Technical success was achieved in all patients, with an overall clinical success rate of 94.6%. Cholecystitis recurred significantly more frequently in the malignant group than in the benign group (13.3% vs. 2.5%; p = 0.015). Univariate analysis identified malignancy as a significant risk factor of recurrence (odds ratio, 5.92; p = 0.028). Conclusions: EUS-GBD is a safe and effective long-term treatment for cholecystitis in non-surgical candidates. However, malignancy-associated cholecystitis carries a high risk of recurrence, warranting careful follow-up and individualized management.


  • Open Access

    Acquiring Higher-Quality Pancreatic Neoplasm Tissue Samples Under Contrast-Enhanced Endoscopic Ultrasound-Guided Fine-Needle Biopsy

    by Hiroyuki Terasawa, Kazuyuki Matsumoto, Takehiro Tanaka, Hirofumi Inoue, Ryosuke Sato, Taisuke Obata, Akihiro Matsumi, Kazuya Miyamoto, Yuki Fujii, Daisuke Uchida, et al.

    Background: Comprehensive Genomic Profiling (CGP) requires sufficient tumor cellularity for successful next-generation sequencing. Pancreatic tumors often develop necrosis, which complicates sample collection. Contrast-enhanced endoscopic ultrasonography (CE-EUS) evaluates tumor viability, potentially improving sampling efficiency. We evaluated whether CE-EUS effectively increases the yield of tumor nuclei (TN) in endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) and improves CGP success rates. Methods: This prospective study included 44 pancreatic neoplasm patients undergoing EUS-FNB for CGP between November 2021 and March 2024. Tumors were classified as non-necrotic or necrotic on CE-EUS images. Tumors in the non-necrotic group were punctured twice at the center (group A), whereas those in the necrotic group were punctured twice from contrast-enhanced (group B) and non-contrast (group C) areas. Percent TN (%TN), tissue section area, DNA integrity number (DIN), DNA concentration, white tissue core length, and histological scores were compared among the three groups. Results: Necrosis was observed in 23 patients (53%). Groups A and B had significantly higher DNA concentrations than group C (group A [n=20]: 0.97 ng/μL; group B [n=23]: 0.42 ng/μL; and group C [n=23]: 0.22 ng/μL: A vs C, PConclusions: Tissue sampling using CE-EUS yielded high-quality specimens, suggesting that CE-EUS is a valuable technique for the treatment of CGP in cases of pancreatic neoplasms (Japan Registry of Clinical Trials no. 1062210071).

  • Open Access

    Efficacy of diagnosing intraductal papillary mucinous neoplasm with mural nodules by contrast-enhanced endoscopic ultrasound using time–intensity curve analysis with a new support program: A multicenter retrospective study (with video)

    by Kazuya Miyamoto, Daisuke Uchida, Kazuyuki Matsumoto, Yosuke Saragai, Tsuneyoshi Ogawa, Toru Ueki, Kei Harada, Nao Hattori, Taisuke Obata, Ryosuke Sato, et al.


  • Open Access

    Evaluation of the Diagnostic Performance of the Brush/Biopsy Rapid On-Site Evaluation (B-ROSE) in Cases of Bile Duct Stricture: A Prospective, Pilot Study

    by Nao Hattori, Daisuke Uchida, Kei Harada, Ryosuke Sato, Taisuke Obata, Akihiro Matsumi, Kazuya Miyamoto, Hiroyuki Terasawa, Yuki Fujii, Koichiro Tsutsumi, et al.

    Background: Biliary strictures are diagnosed using endoscopic retrograde cholangiopancreatography (ERCP) with brush cytology and biopsy. However, brush cytology shows a sensitivity of 9–56.1% and a diagnostic accuracy of 43–65.4%, while biopsy demonstrates a sensitivity of 48%. Both methods exhibit high specificity but limited sensitivity. While rapid on-site evaluation (ROSE) is effective in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA), its application in ERCP-obtained samples remains underexplored. Methods: This prospective pilot study was conducted at Okayama University Hospital from April 2019 to July 2024. Patients requiring ERCP-guided sampling for bile duct strictures were included. ROSE was applied to brush cytology with up to three additional attempts and to imprint cytology from biopsy samples with up to two attempts. Diagnostic accuracy was assessed based on pathology and clinical course. Results: Among 37 patients (median age: 73 years, add range, and male–female ratio: 27:10), 18 had hilar and 19 had distal bile duct strictures. Brush cytology required one, two, or three attempts in twenty-six, six, and five cases, respectively, whereas biopsy required one or two attempts in thirty-five and two cases, respectively. Among the thirty-seven cases, thirty-five were malignant and two were benign. The B-ROSE group showed a sensitivity, specificity, and accuracy of 71.4%, 100.0%, and 73.0%, respectively, compared to lower accuracy in the conventional group, where single brush cytology attempts yielded a sensitivity of 48.6% and an accuracy of 48.6%, and single biopsy attempts showed a sensitivity of 68.6% and an accuracy of 70.3%. Conclusions: B-ROSE improves diagnostic accuracy, reduces repeat sampling, and minimizes patient burden in ERCP-based diagnosis of bile duct strictures, making it a valuable addition to current diagnostic protocols.


  • Open Access

    Double-blind randomized noninferiority study of the effect of pharyngeal lidocaine anesthesia on EUS

    by Yuki Fujii, Kazuyuki Matsumoto, Kei Harada, Nao Hattori, Ryosuke Sato, Taisuke Obata, Akihiro Matsumi, Kazuya Miyamoto, Daisuke Uchida, Shigeru Horiguchi, et al.

    Background and objectives: EUS is typically performed under sedation, often with concomitant analgesics to reduce pain. Traditionally used pharyngeal anesthesia, commonly with lidocaine, may cause pharyngeal discomfort and allergic reactions. This study investigated whether lidocaine-based pharyngeal anesthesia is necessary for EUS under sedation with analgesics. Methods: A double-blind, randomized, noninferiority study was conducted on EUS cases that met the selection criteria. Patients were randomly assigned to receive either 5 sprays of 8% lidocaine (lidocaine group: LG) or saline spray (placebo group: PG) as endoscopy pretreatment. The primary outcome was EUS tolerability, analyzed separately for endoscopists and patients, with a noninferiority margin set at 15%. Secondary outcomes included endoscopist and patient satisfaction, midazolam/pethidine doses, number of gag events, number of esophageal insertion attempts, use of sedative/analgesic antagonists, interruptions due to body movements, throat symptoms after endoscopy, and sedation-related adverse events. Results: Favorable tolerance was 85% in LG and 88% for PG among endoscopists (percent difference: 3.0 [95% confidence interval, −6.6 to 12.6]) and 90% in LG and 91% in PG among patients (percent difference, 0.94 [95% confidence interval, −7.5 to 9.4]). Both groups exceeded the noninferiority margin (P = 0.0002 for endoscopists and patients). Patient satisfaction was significantly higher in PG (P = 0.0080), but no intergroup differences were found in other secondary outcomes. Conclusions: PG was noninferior to LG for pharyngeal anesthesia during EUS with sedation and analgesics. These results suggest that pharyngeal anesthesia with lidocaine can be omitted when performing EUS under sedation with concomitant analgesics. Omitting pharyngeal anesthesia with lidocaine may prevent discomfort and complications caused by pharyngeal anesthesia, shorten examination times, and reduce medical costs.

  • Open Access

    Endoscopic Bridging Stent Placement Improves Bile Leaks After Hepatic Surgery

    by Taisuke Obata, Kazuyuki Matsumoto, Kei Harada, Nao Hattori, Ryosuke Sato, Akihiro Matsumi, Kazuya Miyamoto, Hiroyuki Terasawa, Yuki Fujii, Daisuke Uchida, et al.

    Background: Endoscopic treatment is one of the first-line treatments for bile leaks after hepatic surgery. However, detailed reports of endoscopic treatment for bile leaks after hepatic resection (HR) or liver transplantation (LT) are scarce. The outcomes of endoscopic treatment for bile leaks after hepatic surgery were examined, and factors related to successful treatment were identified. Methods: A total of 122 patients underwent endoscopic treatment for bile leaks after hepatic surgery. The diagnosis of a bile leak is based on the ISGLS criteria. The decision to perform endoscopic retrograde cholangiography (ERC) is made based on the amount of drainage output, laboratory data, clinical symptoms, and CT scan findings. In our study, the site of the bile leak was assessed using ERC. Endoscopic stents were placed to bridge across the bile leak site as much as possible. Otherwise, stents were placed near the leak site. Endoscopic stents were replaced every 2–3 months until an improvement in the bile leak was observed with or without biliary strictures. The outcomes of endoscopic treatment and the factors related to clinical success were evaluated. Results: Seventy-four patients with HR and forty-eight patients with LT were treated endoscopically. Technical and clinical success was achieved in 89% (109/122) and 82% (100/122) of patients, respectively. Three (2%) patients died from uncontrollable bile leaks. Bridging stent placement (p < 0.001), coexistent percutaneous drainage (p = 0.0025), and leak severity (p = 0.015) were identified as independent factors related to the clinical success of endoscopic treatment. During a median observation period of 1162 days after the achievement of clinical success, bile leak recurrence was observed in only three cases (3%). Conclusions: Endoscopic treatment is safe and effective for bile leaks after hepatic surgery. Bridging stent placement across the leak site is the most crucial factor for clinical success.


  • Open Access

    Comparison of Midazolam and Diazepam for Sedation in Patients Undergoing Double-Balloon Endoscopic Retrograde Cholangiopancreatography: A Propensity Score-Matched Analysis

    by Yuki Fujii, Kazuyuki Matsumoto, Akihiro Matsumi, Kazuya Miyamoto, Daisuke Uchida, Shigeru Horiguchi, Koichiro Tsutsumi, Toshiharu Mitsuhashi, Motoyuki Otsuka

    Objective: The sedation method used in double-balloon endoscopic retrograde cholangiopancreatography (DB-ERCP) varies across countries and between healthcare facilities. No previous studies have compared the effects of different benzodiazepines on sedation during endoscopic procedures. This study aimed to compare the effects of midazolam and diazepam sedation on DB-ERCP outcomes. Methods: This retrospective cohort study analyzed consecutive patients who underwent DB-ERCP between January 2017 and February 2024. A total of 203 patients who were sedated with diazepam (n = 94) or midazolam (n = 109) were analyzed. Propensity score matching was applied to adjust for baseline group differences. The primary outcome was the incidence of sedation-related adverse events (AEs). Secondary outcomes included inadequate sedation requiring additional sedatives and risk factors for sedation-related AEs. Results: Sedation-related AEs were more frequent with diazepam (28% [21/75]) than with midazolam (14% [11/75]; p = 0.046). Hypoxia occurred more frequently with diazepam (19% [14/75]) than with midazolam (5% [4/75]; p = 0.012). However, no significant differences were observed between the two groups for hypotension (p = 0.41) and bradycardia (p = 1.0). Poor sedation requiring other sedatives occurred significantly more often with diazepam (8% [6/75]) compared with midazolam sedation (0% [0/75], p = 0.012). Multivariate analysis identified diazepam sedation (odds ratio, 2.3; 95% confidence interval, 1.0–5.3; p = 0.048) as the sole risk factor for sedation-related AEs. Conclusions: Midazolam is safer and more effective than diazepam sedation in patients undergoing DB-ERCP.


  • Open Access

    Salvaging hilar access using an uneven double-lumen cannula in endoscopic ultrasound-guided hepaticogastrostomy

    by Ryosuke Sato, Kazuyuki Matsumoto, Akihiro Matsumi, Kazuya Miyamoto, Yuki Fujii, Daisuke Uchida, Motoyuki Otsuka